Curaleaf Holdings, Inc. (OTCMKTS:CURLF - Get Free Report)'s stock price gapped down before the market opened on Tuesday . The stock had previously closed at $1.24, but opened at $1.20. Curaleaf shares last traded at $1.21, with a volume of 333,782 shares.
Curaleaf Stock Performance
The company has a market capitalization of $784.13 million, a price-to-earnings ratio of -3.77 and a beta of 0.62. The company has a debt-to-equity ratio of 1.08, a quick ratio of 0.70 and a current ratio of 1.41. The firm has a 50-day simple moving average of $0.88 and a two-hundred day simple moving average of $1.05.
Curaleaf (OTCMKTS:CURLF - Get Free Report) last announced its quarterly earnings data on Thursday, May 8th. The company reported ($0.07) earnings per share (EPS) for the quarter, meeting the consensus estimate of ($0.07). Curaleaf had a negative return on equity of 14.12% and a negative net margin of 17.37%. On average, sell-side analysts anticipate that Curaleaf Holdings, Inc. will post -0.25 EPS for the current fiscal year.
About Curaleaf
(
Get Free Report)
Curaleaf Holdings, Inc operates a cannabis operator in the United States. It operates through two segments, Domestic Operations and International Operations. The company offers flower, pre-rolls, flower pots, and dry-herb vaporizer cartridges; concentrates for vaporizing which includes pre-filled vaporizer cartridges and disposable vaporizer pens; and concentrates for dabbing, such as mints, distillate droppers, mints, topical balms and lotions, tinctures, lozenges, capsules, and edibles.
Read More
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Curaleaf, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Curaleaf wasn't on the list.
While Curaleaf currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.